Open AccessMidkine level may be used as a noninvasive biomarker in Crohn’s disease
Author(s) -
Murat Kekilli,
Alpaslan Tanoğlu,
Fatih Karaahmet,
Zeynal Doğan,
Murat Çan,
Abdurrahim Sayılır,
Başak Çakal,
Tolga Düzenli,
Yavuz Beyazıt
Publication year - 2020
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-1904-167
Subject(s) - midkine , medicine , biomarker , crohn's disease , gastroenterology , inflammation , disease , inflammatory bowel disease , ulcerative colitis , venous blood , immunology , biochemistry , chemistry , receptor , growth factor
Crohn’s disease (CD) is a kind of inflammatory bowel disease. Midkine (MDK) is an endogenous inflammatory marker. We aimed to investigate the relationship between MDK levels and inflammation and hence determine whether MDK can be used as a noninvasive biomarker in active CD.